Latest & greatest articles for geriatrics

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on geriatrics or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on geriatrics and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for geriatrics

121. The CHIRPY DRAGON intervention in preventing obesity in Chinese primary-school--aged children: A cluster-randomised controlled trial Full Text available with Trip Pro

The CHIRPY DRAGON intervention in preventing obesity in Chinese primary-school--aged children: A cluster-randomised controlled trial The CHIRPY DRAGON Intervention in Preventing Obesity in Chinese Primary-School--Aged Children: A Cluster-Randomised Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced (...) characters Choose a collection: Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation Randomized Controlled Trial PLoS Med Actions , 16 (11), e1002971 2019 Nov 26 eCollection Nov 2019 The CHIRPY DRAGON Intervention in Preventing Obesity in Chinese Primary-School--Aged Children: A Cluster-Randomised Controlled Trial , , , , , , , , , , , Affiliations Expand

2020 EvidenceUpdates

122. Examining the relationship between triage acuity and frailty to inform the care of older emergency department patients: Findings from a large Canadian multisite cohort study (Abstract)

Examining the relationship between triage acuity and frailty to inform the care of older emergency department patients: Findings from a large Canadian multisite cohort study The 2016 Canadian Triage and Acuity Scale (CTAS) updates introduced frailty screening within triage to more accurately code frail patients who may deteriorate waiting for care. The relationship between triage acuity and frailty is not well understood, but may help inform which supplemental geriatric assessments (...) are beneficial to support care in the emergency department (ED). Our objectives were to investigate the relationship between triage acuity and frailty, and to compare their associations with a series of patient outcomes.We conducted a secondary analysis of the Canadian cohort from a multinational prospective study. Data were collected on ED patients 75 years of age and older from eight ED sites across Canada between November 2009 and April 2012. Triage acuity was assigned using the CTAS, whereas frailty

2020 EvidenceUpdates

123. Testosterone Treatment in Adult Men With Age-Related Low Testosterone: A Clinical Guideline From the American College of Physicians. (Abstract)

Testosterone Treatment in Adult Men With Age-Related Low Testosterone: A Clinical Guideline From the American College of Physicians. The American College of Physicians (ACP) developed this guideline to provide clinical recommendations based on the current evidence of the benefits and harms of testosterone treatment in adult men with age-related low testosterone. This guideline is endorsed by the American Academy of Family Physicians.The ACP Clinical Guidelines Committee based (...) these recommendations on a systematic review on the efficacy and safety of testosterone treatment in adult men with age-related low testosterone. Clinical outcomes were evaluated by using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system and included sexual function, physical function, quality of life, energy and vitality, depression, cognition, serious adverse events, major adverse cardiovascular events, and other adverse events.The target audience includes all clinicians

2020 Annals of Internal Medicine

124. Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United States. (Abstract)

effects from the current HPV vaccination program.The current HPV vaccination program is predicted to be cost saving. Extending vaccination to older ages is predicted to produce small additional health benefits and result in substantially higher incremental cost-effectiveness ratios than the current recommendation.Centers for Disease Control and Prevention. (...) Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United States. In the United States, the routine age for human papillomavirus (HPV) vaccination is 11 to 12 years, with catch-up vaccination through age 26 years for women and 21 years for men. U.S. vaccination policy on use of the 9-valent HPV vaccine in adult women and men is being reviewed.To evaluate the added population-level effectiveness and cost-effectiveness of extending the current U.S

2020 Annals of Internal Medicine

125. Predicting 6-Month Mortality for Older Adults Hospitalized With Acute Myocardial Infarction: A Cohort Study. (Abstract)

study. (ClinicalTrials.gov: NCT01755052).94 hospitals throughout the United States.3006 persons aged 75 years or older who were hospitalized with AMI and discharged alive.Functional impairments were assessed during hospitalization via direct measurement (cognition, mobility, muscle strength) or self-report (vision, hearing). Clinical variables associated with mortality in prior risk models were ascertained by chart review. Seventy-two candidate variables were selected for inclusion, and backward (...) Predicting 6-Month Mortality for Older Adults Hospitalized With Acute Myocardial Infarction: A Cohort Study. Older adults with acute myocardial infarction (AMI) have higher prevalence of functional impairments, including deficits in cognition, strength, and sensory domains, than their younger counterparts.To develop and evaluate the prognostic utility of a risk model for 6-month post-AMI mortality in older adults that incorporates information about functional impairments.Prospective cohort

2020 Annals of Internal Medicine

126. Combination non-pharmacologic intervention for orthostatic hypotension in older people: a phase 2 study Full Text available with Trip Pro

to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation Age Ageing Actions 2019 Dec 23 [Online ahead of print] Combination Non-Pharmacologic Intervention for Orthostatic Hypotension in Older People: A Phase 2 Study , Affiliations Expand Affiliations 1 Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK. 2 The Falls and Syncope Service, Newcastle upon Tyne (...) Hospitals NHS Foundation Trust, Newcastle upon Tyne NE1 4LP, UK. 3 NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Trust and Newcastle University, Newcastle upon Tyne, UK. PMID: 31868889 DOI: Item in Clipboard Combination Non-Pharmacologic Intervention for Orthostatic Hypotension in Older People: A Phase 2 Study James Frith et al. Age Ageing . 2019 Show details Age Ageing Actions Authors , Affiliations 1 Institute of Cellular Medicine, Newcastle University, Newcastle upon

2020 EvidenceUpdates

127. Ageing and mobility: A grand challenge

as a barrier to use and improvement. This results in difficulties for individuals to navigate the systems and weakens system-wide incentives for integration and innovation. On average at least one-third of older people report unmet travel needs. It worsens with age, and women were reported to be more affected than men. (Luiu et al 2016). Mobility challenges faced in later life6 © Centre for Ageing Better 20197 © Centre for Ageing Better 2019 As we grow older, we are more likely to have health conditions (...) % of older people cannot reach a hospital within 30 minutes by public transport. (Future of Mobility: Evidence Review). Accessible and inclusive new technologies, services and business models Opportunities for innovation8 © Centre for Ageing Better 2019 Specific issues to address in their development include: - New vehicles, including Autonomous Vehicles, need to be designed to be accessible for people with limited mobility. - Addressing the door to vehicle portion of the journey, which can

2020 The Centre for Ageing Better

128. The State of Ageing in 2019: Adding life to our years

occupations. Pessimism about getting older is also linked to poorer health. People who worry about their health getting worse and those who expect to get lonely are around 30% more likely to have a negative experience of ageing than people who don’t. 31 8% 6% 5% 3% 3% 25 to 34 year olds 50 to 64 year olds 35 to 49 year olds 65 to 74 year olds 75 and over professional occupations routine occupations 7% 20% Later lives todayHow will future generations experience later life? In less than 20 years, the number (...) at risk. HealthHousing The majority of people continue to live in mainstream houses as they grow older, rather than moving into specialist accommodation, and increasing numbers of over 50s are renting. Yet UK housing stock is by and large unsuitable for people to grow old in.The State of Ageing in 2019 Adding life to our years 27 Housing With 38% of our homes dating from before 1946 (21% from before 1919), and just 7% from after 2000, the UK has the oldest housing stock in the EU. 69 Unsurprisingly

2020 The Centre for Ageing Better

129. Efficacy, safety, and tolerability of mirabegron in patients aged >/=65yr with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (PILLAR)

. Safety and tolerability were consistent with the known mirabegron safety profile. Conclusions: Mirabegron efficacy, safety, and tolerability over 12 wk were confirmed in patients aged ≥65yr with OAB and incontinence. Patient summary: We examined the effect of mirabegron compared with placebo in people aged 65yr or older with overactive bladder and incontinence. Mirabegron improved the symptoms of overactive bladder compared with placebo. Side effects were similar to those already known for mirabegron (...) of Mirabegron in Patients Aged ≥65yr With Overactive Bladder Wet: A Phase IV, Double-Blind, Randomised, Placebo-Controlled Study (PILLAR) Adrian Wagg et al. Eur Urol . Feb 2020 Show details Eur Urol Actions , 77 (2), 211-220 Authors , , , , , Affiliations 1 Geriatric Medicine, University of Alberta, Edmonton, Alberta, Canada. Electronic address: adrian.wagg@ualberta.ca. 2 Division of Urology, St Elizabeth's Medical Center, Boston, MA, USA. 3 Bayview Research Group, LLC, Valley Village, CA, USA. 4 Sunnybrook

2020 EvidenceUpdates

130. State of Ageing 2019 infographics

and Chelsea Disability free life expectancy Total life expectancySource: +"CFMMBOE/"NJO4NJUIFUBM 5IF%ZOBNJDTPG"HF JOH &WJEFODFGSPNUIF&OHMJTI-POHJUVEJOBM4UVEZPG"HFJOH 8BWF 1 in 5 people aged 55-64 have a health problem that limits the kind of work they can doSource: +"CFMMBOE/"NJO4NJUIFUBM 5IF%ZOBNJDTPG"HF JOH &WJEFODFGSPNUIF&OHMJTI-POHJUVEJOBM4UVEZPG"HFJOH 8BWF More than a quarter of the poorest men aged 50 and over are smokers, compared to 5% of the wealthiest 27% 5% 5% 19% 1 oor FTURu J O UJMe 8 FB (...) &WJEFODFGSPNUIF&OHMJTI-POHJUVEJOBM4UVEZPG"HFJOH 8BWF Compared to the wealthiest quintile, the poorest quintile of men aged 50 and over are: 3x 2x 2x NPr FMJ L e M Z U o h B W e chronic heart disease N or FMJ L e M Z U o h B W e Type 2 diabetes N or FMJ L e M Z U o h BWe arthritis4PVSDF0tDFPG/BUJPOBM4UBUJTUJDT .FBTVSJOHOBUJPOBMXFMMCFJOH EPNBJOTBOENFBTVSFT CBTFE - POFMJOFTTB T FDUT QFPQMFP GBMMBHFT 8% 6% 5% 3% 3% 25 to 34 year olds 50 to 64 year olds 35 to 49 year olds 65 to 74 year olds 75 and over

2020 The Centre for Ageing Better

131. Measuring ageing: An introduction to the Ageing Better Measures Framework

Better 2019 Local monitoring and evaluation We are also making use of the ABMF at a local level. We are working with the Greater Manchester Combined Authority, Leeds City Council and Leeds Older People’s Forum, supporting them, as well as other members of the UK Network of Age-Friendly Communities, in their use of data and measures to understand local experiences of ageing and monitor progress. We look forward to continuing to work with these and other partners interested in measuring what matters (...) Measuring ageing: An introduction to the Ageing Better Measures Framework Measuring ageing: An introduction to the Ageing Better Measures Framework Centre for Ageing Better January 20193 © Centre for Ageing Better 2019 About the Centre for Ageing Better The Centre for Ageing Better is a charity, funded by an endowment from The National Lottery Community Fund, working to create a society where everyone enjoys a good later life. We want more people to be in fulfilling work, in good health, living

2020 The Centre for Ageing Better

132. Preventing respiratory illness in older adults aged 60 years and above living in long-term care

Preventing respiratory illness in older adults aged 60 years and above living in long-term care Preventing respiratory illness in older adults aged 60 years and above living in long-term care - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website Preventing respiratory illness in older adults aged 60 years and above living in long-term care March 28, 2020 Patricia Rios, Amruta Radhakrishnan, Sonia M. Thomas (...) ) or mixed evidence of effectiveness (e.g., rimantadine, zanamivir, hand hygiene, personal protective equipment). The mixed evidence on hand hygiene and use of personal protective equipment does not imply these should not be used in outbreaks BACKGROUND The Infection Prevention & Control of the World Health Organization (WHO) Health Emergency Programme commissioned a review on preventing and managing COVID-19 in older adults aged 60 years and above living in long-term care facilities. The overall

2020 Oxford COVID-19 Evidence Service

133. Guidelines for preventing respiratory illness in older adults aged 60 years and above living in long-term care

Guidelines for preventing respiratory illness in older adults aged 60 years and above living in long-term care Guidelines for preventing respiratory illness in older adults aged 60 years and above living in long-term care - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website Guidelines for preventing respiratory illness in older adults aged 60 years and above living in long-term care March 28, 2020 Patricia (...) , these recommendations should be viewed with caution as it is unclear how many of these guidelines are based on the best available evidence due to their poor overall quality. BACKGROUND The Infection Prevention & Control of the World Health Organization (WHO) Health Emergency Programme commissioned a review on preventing and managing COVID-19 in older adults aged 60 years and above living in long-term care facilities. The overall objective of this rapid review of clinical practice guidelines was to identify

2020 Oxford COVID-19 Evidence Service

134. COVID-19 and medicines advice for older people

COVID-19 and medicines advice for older people COVID-19 and medicines advice for older people | British Geriatrics Society Toggle main menu visibility Search Search Search COVID-19 and medicines advice for older people Stay at home advice: Feedback on this resource? Email If you’d like us to contact you, please leave your email Your feedback * CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Other resources in this series (...) Contact us British Geriatrics Society Marjory Warren House 31 St John’s Square London EC1M 4DN Tel: +44 (0)20 7608 1369 Fax: +44 (0)20 7608 1041 Quick links Follow us Sign up for our e-bulletin Built by

2020 British Geriatrics Society

135. COVID-19: Geriatric basics for non-specialists

COVID-19: Geriatric basics for non-specialists COVID-19: Geriatric basics for non-specialists | British Geriatrics Society Toggle main menu visibility Search Search Search COVID-19: Geriatric basics for non-specialists Delirium Comprehensive Geriatric Assessment (CGA) External materials These materials have been developed by external organisations for people who are not necessarily specialists in geriatric medicine or the healthcare of older people and may be of use in some clinical and non (...) . Current advice Other resources in this series Contact us British Geriatrics Society Marjory Warren House 31 St John’s Square London EC1M 4DN Tel: +44 (0)20 7608 1369 Fax: +44 (0)20 7608 1041 Quick links Follow us Sign up for our e-bulletin Built by

2020 British Geriatrics Society

136. COVID-19: Rapidly managing pneumonia in older people during a pandemic

adults is preferable to treating it. Identification of the early stages of pneumonia in older patients can prove difficult. Traditional symptoms and signs, including fever, may be absent. Limited evidence suggests that many tests that are useful in younger patients do not help . The onset of pneumonia in elderly people can often be rapid, and the prognosis is poor in severe pneumonia: The older you are, the more prevalent becomes. Patients in appear to fare even worse, as they often have several (...) comorbidities and poor nutritional status and are often physically inactive. In-hospital mortality is significantly higher, even after adjusting for age and sex. Common causative organisms in elderly people admitted to hospital with pneumonia include Streptococcus pneumoniae and Mycoplasma pneumoniae . Less commonly, Haemophilus influenzae and Staphylococcus aureus may be responsible. In severe pneumonia, S. aureus , Klebsiella pneumoniae , and Pseudomonas aeruginosa are common causative organisms

2020 Oxford COVID-19 Evidence Service

137. COVID-19: The relationship between age, comorbidity, and disease severity – a rapid review

of COVID-19 than among those who survive. However, as chronic diseases are more common among older people, it is difficult to determine whether the increased risk among the elderly is due to comorbidity, age, or a combination of these factors. Age and/or comorbidity? We identified three studies analysing multiple risk factors using multivariate mod- els, but the results do not provide clear answers as to whether age or comorbidity is the most important risk factor for serious illness. It seems (...) ] OR Neoplasms[mh]OR can- cer*[tw] OR immunosuppress*[tw] OR Aged[mh] OR "Middle Aged"[mh] OR "Young Adult"[mh] OR "age group"[tw] OR "age groups"[tw] OR elderly[tw] OR aged[tw] OR middleaged[tw] OR "old people"[tw])) AND systematic[sb] 4 hits Main search, PubMed – age groups, without demarcation on publication type: ((((Coronavirus[mh] OR "Coronavirus Infections"[mh] OR "corona virus"[tw] OR coro- navirus[tw] OR coronovirus[tw]) AND (novel[tw]OR 2019[tw] OR Wuhan[tw])) OR "COVID-19"[tw] OR COVID19[tw

2020 Norwegian Institute of Public Health

138. Guidelines for preventing respiratory illness in older adults aged 60 years and above living in long-term care: A rapid review of clinical practice guidelines

Guidelines for preventing respiratory illness in older adults aged 60 years and above living in long-term care: A rapid review of clinical practice guidelines Guidelines for preventing respiratory illness in older adults aged 60 years and above living in long-term care: A rapid review of clinical practice guidelines | medRxiv Search for this keyword Guidelines for preventing respiratory illness in older adults aged 60 years and above living in long-term care: A rapid review of clinical practice (...) of Toronto For correspondence: Abstract Background: The overall objective of this rapid review was to identify infection protection and control recommendations from published clinical practice guidelines (CPGs) for adults aged 60 years and older in long-term care settings Methods: Comprehensive searches in MEDLINE, EMBASE, the Cochrane Library, and relevant CPG publishers/repositories were carried out in early March 2020. Title/abstract and full-text screening, data abstraction, and quality appraisal

2020 Covid-19 Ad hoc guidelines

139. COVID-19: The relationship between age, comorbidity and disease severity – a rapid review

of different comorbidi- ties, but a study by Petrilli and co-workers contributes valuable data. The authors followed a cohort consisting of 4103 patients with COVID-19, and explored charac- teristics of patients admitted to hospital. They found that the risk of hospitalisation increased with age: Compared to patients between 19 and 44 years old, the odds ra- tio (OR) was 4.17 (95% CI 3.35 to 5.2) for people between 55 and 64, 10.91 (95% CI 8.35 to 14.34) for people between 65 and 74, and 66.79 (44.73 (...) -102.62) for people aged 75 or older. High BMI, heart failure, chronic kidney disease, diabetes and male gender were identified as independent predictors of hospitalisation (Table 1). Table 1 Studies assessing risk factors predicting more severe disease Reference Outcome Factors tested Factors included in multivariate model Dong et al (10) N=135 China Mild vs Severe course NA # Age Comorbidity OR 1.04 (1.01-1.97) OR 1.7 (1.1-2.8) Hu et al (11) N=323 China Favorable vs. unfavorable§ Age, BMI, CVD

2020 Norwegian Institute of Public Health

140. COVID-19 and the ‘old-fashioned’ idea of neighbourhoods

COVID-19 and the ‘old-fashioned’ idea of neighbourhoods COVID-19 and the ‘old-fashioned’ idea of neighbourhoods - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website COVID-19 and the ‘old-fashioned’ idea of neighbourhoods June 8, 2020 Dr Patrícia Canelas Departmental Lecturer, Sustainable Urban Development Programme, University of Oxford Dr Idalina Baptista Associate Professor, Sustainable Urban Development

2020 Oxford COVID-19 Evidence Service